Cancer Epigenetics


Cancer epigenetics is the study of epigenetic mutations in the DNA of cancer cells that do not involve genetic sequence modification, but rather involves mutations in the way genetic code is expressed. Epigenetic processes are required to maintain normal tissue specific gene expression sequence and are essential for normal development. They may be equally important, or even more important, than the genetic mutation in a cell. Disruption of epigenetic processes in cancer, can lead to a loss of gene expression that occurs about 10 times by documentation rather than mutation.


    Related Conference of Cancer Epigenetics

    March 09-10, 2026

    21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Singapore City, Singapore
    April 16-17, 2026

    19th World Congress on Stem Cell Research

    Tokyo, Japan
    April 23-24, 2026

    9th Annual Conference on Stem Cell and Regenerative Medicine

    Dubai, UAE
    May 04-05, 2026

    14th World Congress on Human Genetics and Genetic Diseases

    Paris, France
    May 25-26, 2026

    20th International Conference on Regenerative Repair and Medicine

    Madrid, Spain
    June 08-09, 2026

    9th Global Conference on Cell and Gene Therapy

    Rome, Italy
    June 15-16, 2026

    22nd Global Summit on Stem Cell & Regenerative Medicine

    Amsterdam, Netherlands
    June 15-16, 2026

    13th World Congress on Epigenetics and Chromosome

    Paris, France
    June 18-19, 2026

    16th International Conference on Human Genetics and Genetic Diseases

    Singapore City, Singapore
    June 18-19, 2026

    19th International Conference on Genomics & Pharmacogenomics

    Singapore City, Singapore
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Cancer Epigenetics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in